| [1] |
Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults[J]. Circulation, 1995, 92(4):785-789.
|
| [2] |
殷昆仑. 肥厚梗阻型心肌病的基因型-表型-病理改变的关联分析及转录组学研究[D].北京:北京协和医学院,2019.
|
| [3] |
Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis[J]. BMC Bioinformatics, 2008, 9:559.
|
| [4] |
Piñero J, Bravo À, Queralt-Rosinach N, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants[J]. Nucleic Acids Res, 2017, 45(D1):D833-D839.
|
| [5] |
Han H, Cho JW, Lee S, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions[J]. Nucleic Acids Res, 2018, 46(D1):D380-D386.
|
| [6] |
Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible[J]. Nucleic Acids Res, 2017, 45(D1):D362-D368.
|
| [7] |
Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks[J]. Genome Res, 2003, 13(11):2498-2504.
|
| [8] |
Li J, Diao B, Guo S, et al. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism[J]. Nat Commun, 2017, 8(1):1322.
|
| [9] |
Huang X, Feng Z, Jiang Y, et al. VSIG4 mediates transcriptional inhibition of Nlrp3 and IL-1β in macrophages[J]. Sci Adv, 2019, 5(1):eaau7426.
|
| [10] |
Kitz S, Fonfara S, Hahn S, et al. Feline hypertrophic cardiomyopathy: the consequence of cardiomyocyte-initiated and macrophage-driven remodeling processes?[J]. Vet Pathol, 2019, 56(4):565-575.
|
| [11] |
Ptaszynska-Kopczynska K, Marcinkiewicz-Siemion M, Lisowska A, et al. Alterations of soluble TWEAK and CD163 concentrations in patients with chronic heart failure[J]. Cytokine, 2016, 80:7-12.
|
| [12] |
Allen RD, Edwards WD, Tazelaar HD, et al. Surgical pathology of subaortic septal myectomy not associated with hypertrophic cardiomyopathy: a study of 98 cases (1996-2000)[J]. Cardiovasc Pathol, 2003, 12(4):207-215.
|
| [13] |
Fang L, Ellims AH, Beale AL, et al. Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy[J]. Am J Transl Res, 2017, 9(11):5063-5073.
|
| [14] |
Haudek SB, Trial J, Xia Y, et al. Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells[J]. Proc Natl Acad Sci U S A, 2008, 105(29):10179-10184.
|
| [15] |
van Beek L, Vroegrijk IO, Katiraei S, et al. FcRγ-chain deficiency reduces the development of diet-induced obesity[J]. Obesity (Silver Spring), 2015, 23(12):2435-2444.
|
| [16] |
Pak Y, Glowacka WK, Bruce MC, et al. Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination[J]. J Cell Biol, 2006, 175(4):631-645.
|
| [17] |
Ouchida R, Kurosaki T, Wang JY. A role for lysosomal-associated protein transmembrane 5 in the negative regulation of surface B cell receptor levels and B cell activation[J]. J Immunol, 2010, 185(1):294-301.
|
| [18] |
Glowacka WK, Alberts P, Ouchida R, et al. LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages[J]. J Biol Chem, 2012, 287(33):27691-27702.
|
| [19] |
Nuylan M, Kawano T, Inazawa J, et al. Down-regulation of LAPTM5 in human cancer cells[J]. Oncotarget, 2016, 7(19):28320-28328.
|